Vascular endothelial growth factor (VEGF, VEGF-A), a selective mitogen for endothelial cells is a critical factor for vascular development. Two isoforms that differ in the presence of exons 6 and 7, Vegf 165 and Vegf 121 , are the dominant forms expressed in zebrafish embryo. Simultaneous overexpression of both isoforms in the embryo results in increased production of flk1, tie1, scl, and gata1 transcripts, indicating a stimulation of both endothelial and hematopoietic lineages. We also demonstrate that vegf can stimulate hematopoiesis in zebrafish by promoting the formation of terminally differentiated red blood cells. Simultaneous overexpression of both isoforms also causes ectopic vasculature and blood cells in many of the injected embryos as well as pericardial edema in later stage embryos. Overexpression of vegf also resulted in earlier onset of flk1, tie1, scl, and gata1 expression in the embryo, indicating a possible role of vegf in stimulating the differentiation of both vascular and hematopoietic lineages. Co-injection of RNAs for both isoforms results in increased expression of three of these markers over and above that observed when either RNA is singly injected and analysis of vegf expression in the notochord mutants no tail and floating head suggests that the notochord patterns the formation of the dorsal aorta by stimulating adjacent somite cells to express vegf, which in turn functions as a signal in dorsal aorta patterning. Finally, studies of vegf expression in cloche mutant indicate that vegf expression is generally independent of cloche function. These results show that in the zebrafish embryo, vegf can not only stimulate endothelial cell differentiation but also hematopoiesis. Moreover, these effects are most dramatic when both vegf isoforms are co-expressed, indicating a synergistic effect of the expression of the two forms of the VEGF protein. q
Introduction
Vascular endothelial growth factor (VEGF, VEGF-A), a selective mitogen for endothelial cells, is an important growth factor for vascular development and angiogenesis. Two endothelium-specific receptor tyrosine kinases, VEGFR1/Flt-1 and VEGFR2/Flk-1, serve as high-affinity VEGF receptors in various vertebrate systems (Millauer et al., 1993; reviewed in Ferrara and Davis-Smyth, 1997; Neufeld et al., 1999) . The VEGF signaling transduction pathway has been shown to play critical roles in embryonic vasculogenesis and angiogenesis (respectively, the formation and sprouting of blood vessels), during which both Flt-1 and Flk-1 are present in the endothelial cells (Breier et al., 1992 (Breier et al., , 1995 Millauer et al., 1993; Flamme et al., 1995a; Yamaguchi et al., 1993; Quinn et al., 1993; Dumont et al., 1995; Fong et al., 1995; Cleaver et al., 1997; Fouquet et al., 1997; Liao et al., 1997) , including the endocardium (Yamaguchi et al., 1993; Dumont et al., 1995) . In addition, both Flk-1 and Flt-1 are expressed in hemangioblasts (Eichmann et al., 1997; Choi et al., 1998) , the common precursor of endothelial and hematopoietic cells (reviewed in Robb and Elefanty, 1998) .
Mice lacking even one VEGF allele form abnormal blood vessels and die during embryogenesis between days 11 and 12 and homozygous VEGF-deficient mice develop even fewer endothelial cells (Carmeliet et al., 1996; Ferrara et al., 1996) . Recently, it has been shown by a morpholino antisense oligonucleotide inhibition study that loss of vegf function results in blood vessel deficiencies and the enlargement of the pericardium (Nasevicius et al., 2000) . Loss of function of the VEGF receptors indicates a requirement for the VEGF pathway in endothelial development, and in this case, hematopoietic development as well. Homozygous Flk-1 null mice die between E8.5 and E9.5 days and show a block in differentiation of mesoderm to endothelial or hematopoietic cells (Shalaby et al., 1995) . Cells lacking Flk-1 cannot migrate to form blood islands and have very reduced potential to contribute to hematopoiesis (Shalaby et al., 1997) . In contrast, Flt-1 null mice do form endothelial cells and hematopoietic precursors, but the endothelial cells fail to be organized into normal vascular channels . It seems that the primary defect in the Flt-1 2/2 mice is excessive formation of hemangioblasts, which leads to the formation of disorganized vasculature (Fong et al., 1999) .
VEGF is consistently expressed at high levels in close proximity to the developing endothelium of the early quail, mouse, and Xenopus embryos (Breier et al., 1992; Dumont et al., 1995; Flamme et al., 1995a; Cleaver et al., 1997; Cleaver and Krieg, 1998; Miquerol et al., 2000) . Even modest overexpression of the VEGF from its endogenous locus in mice results in severe abnormalities in heart development and embryonic lethality (Miquerol et al., 2000) . Quail embryos injected with VEGF protein resulted in ectopic vascularization and excessive fusion of vessels (Drake and Little, 1995) , although another study in which VEGF was delivered to quail limb buds using a retroviral vector reported an increase in vascular density but no premature vascularization (Flamme et al., 1995b) . Ectopic VEGF protein also results in the proliferation of endocardial cells in the quail embryo (Feucht et al., 1997) . Xenopus embryos injected with VEGF RNA or plasmid DNA form a large number of ectopic endothelial precursor cells and later develop large, disorganized vascular structures (Cleaver et al., 1997) . There are also a number of examples of ectopic angiogenesis resulting from the administration of VEGF. For example, porcine keratinocytes designed to express high levels of VEGF can induce angiogenesis in adjacent tissue when transplanted into the stroma of pig skin (Rio et al., 1999) and human fibrosarcoma cells transfected with VEGF cDNA are reported to induce angiogenesis around tumors after injection of these cells into mice (Mori et al., 1999) . Ectopic expression of VEGF has in fact been used therapeutically to induce angiogenesis in the limbs of rodents (Takeshita et al., 1994; Tsurumi et al., 1997) and humans with peripheral vascular deficiencies (Isner et al., 1996; Baumgartner et al., 1998) . None of these studies to our knowledge, however, has reported an effect of VEGF expression on hematopoiesis.
The human VEGF gene is organized into eight exons, separated by seven introns (Tisher et al., 1991) . Alternative splicing generates six isoforms of VEGF mRNA and peptides in human (121, 145, 165, 183, 189, and 206) reviewed in Ferrara and Davis-Smyth, 1997; Neufeld et al., 1999) . The various VEGF mRNA isoforms are distinguished by the presence or absence of exons 6 and 7 of the VEGF gene, which confer heparin and heparin-sulfate binding ability. While VEGF 121 lacks both exons, VEGF 165 lacks only exon 6. The zebrafish system has been shown to be advantageous for the study of vertebrate cardiovascular systems (Stainier and Fishman, 1994) . Previously, we have characterized a zebrafish vegf 165 cDNA and studied the expression of the vegf 165 transcript by reverse trancriptase polymerase chain reaction (RT-PCR), and used whole-mount in situ hybridization to show that vegf is expressed strongly in four areas of the 18-19 h post-fertilization (hpf) zebrafish embryo (Liang et al., 1998) . The areas that revealed strong expression are in the prospective optic stalk within the anterior central nervous system, in mesoderm overlapping the bilaterally located merging heart fields, in mesoderm underlying and flanking the hindbrain posterior to rhombomere 4, and in medial regions of the somites (Liang et al., 1998) . In this study, we report the identification of another vegf isoform in zebrafish, vegf 121 , and present a detailed analysis of the expression of vegf gene during embryogenesis. We demonstrate that the ectopic expression of vegf in the zebrafish embryo not only stimulates the endothelial cell formation, but also expands the hematopoietic lineage. The two isoforms together appear to function more potently than either isoform alone. Furthermore, we show that forced expression of the two vegf isoforms can induce the earlier onset of both vascular endothelial and hematopoietic marker genes. Finally, the expression patterns of vegf in cloche (clo), no tail, (ntl) and floating head ( flh) suggest that vegf expression is generally independent of clo and the notochord may have a role in regulating vegf expression in the somites.
Results

The temporal expression profile of the two vegf isoforms during zebrafish embryogenesis
VEGF exists in multiple, differentially spliced isoforms in various species (reviewed in Ferrara and Davis-Smyth, 1997; Neufeld et al., 1999) . We have previously isolated the vegf 165 isoform from zebrafish and analyzed its expression in early embryos (Liang et al., 1998) . To determine if other isoforms of vegf exist in the zebrafish, primers flanking the entire coding region were designed and used in RT-PCR reactions with total RNA of adult fish. As shown in the upper panel of Fig. 1 , three RT-PCR products (bands a-c) were generated, and the identities of these bands were determined by sequencing. The 623 bp fragment (band a) corresponds to the published zebrafish vegf 165 that contains exons equivalent to exons 1-5, 7, and 8 of the human VEGF gene (Tisher et al., 1991; Liang et al., 1998 
Expression patterns of vegf during embryogenesis
To further analyze the temporal and spatial expression of vegf, we performed whole-mount in situ hybridization of embryos up to the 72 hpf stage using a probe which would identify either vegf isoform. The spatial expression of vegf is first localized on the dorsal side of the embryos at about 80% epiboly ( Fig. 2A) . At 12 hpf, vegf is expressed in a region adjacent to the yolk throughout the embryo (Fig.  2B) . Starting from 15 to 16 hpf ( Fig. 2C-E) , the vegf is expressed bilaterally in four regions (anterior forebrain, mesoderm underlining and lateral to the anterior hindbrain, mesoderm underlining and lateral to the posterior hindbrain, and the ventral medial portions of the somites), as we previously reported for the 18-19 hpf embryo (Liang et al., 1998) . It is possible that the expression in the mesoderm lateral to the anterior and posterior hindbrain is in the precursors to the heart and aortic arches. We also saw expression at this stage in the midbrain-hindbrain boundary (data not shown). However, no vegf expression was observed in the intermediate cell mass (ICM), which is an active site for genesis of vascular and hematopoietic cells ( Fig. 2J) (Reib, 1973; Al-Adhami and Kunz, 1977; Parker et al., 1999) . At 24 hpf, strong expression was maintained in the above-mentioned regions with additional expression found in a region of the gut corresponding to the developing glomeruli, underneath the second and third somite pairs just ventral to the merging dorsal aortae (Fig.  2G,H) . By 30-36 hpf, expression in the somites is greatly decreased, while strong expression is now observed in a region corresponding to the developing glomeruli (Majumdar et al., 2000) and to the anterior portion of the pronephric ducts, the pharyngeal arches, and the brain (Fig.  2L,M,O) . At 48 hpf, the expression in the glomeruli and anterior pronephric duct region remains strong (white star, Fig. 2Q ), correlating with the active vascularization of the pronephros in this period (Drummond et al., 1998; Majumdar and Drummond, 1999) . In addition, a weak signal was also detected in the peri-anal region at this stage (thin arrow, Fig. 2Q ). By 72 hpf, vegf expression has markedly decreased in the pronephros region and is not detectable elsewhere in the embryo (data not shown). No obvious expression was observed in the hypochord (Eriksson and Lofberg, 2000) .
Since VEGF is known to function in mammals through activation of the endothelial cell-specific tyrosine kinase receptors Flk-1 and Flt-1, we compared the expression pattern of vegf with the expression sites of the zebrafish flk1. flk1, an early endothelial lineage marker, is first expressed in the zebrafish embryo at approximately 12 hpf, 4 h after we first detected vegf transcripts, in the cephalic regions and in the posterior lateral mesoderm (Fouquet et al., 1997; Liao et al., 1997; Sumoy et al., 1997) . At this time, when flk1 first appears in a few cells in the lateral mesoderm, vegf is present throughout the ventral embryonic body. By 15-19 hpf, we confirmed that flk1 was expressed in prospective head vessels, in prospective endocardial cells in the head mesoderm, and in the forming aorta (data not shown), all areas adjacent to the vegf expressing tissue. By 24 hpf, while flk1 is present in the major trunk vessels as well as the forming intersomitic vessels (Fouquet et al., 1997; Liao et al., 1997; Sumoy et al., 1997; Fig. 2F,I) , vegf is expressed very strongly in the adjacent somite areas (Fig. 2G ,H,J). In addition, the site of strong vegf expression in the nephron primordia was located immediately ventral to the junction of the paired dorsal aortae that express flk1 (Fig. 2M) . The increase in expression of vegf in the anterior pronephric duct region from 24 to 48 hpf also correlates with flk1 expression in this region ( Fig. 2K-Q) . We also observed expression of both vegf and flk1 in the peri-anal region of 48 hpf embryos (Fig. 2P ,Q, thin arrows). Both vegf and flk1 expressions decrease significantly by 72 hpf. Although most of the vegf and flk1 expressing tissues are adjacent to one another, there is at least one region in which this correlation is not observed -vegf is distinctly absent in the posterior ICM at 24 hpf (Fig. 2I , arrow) when flk1 is strongly expressed at this site (Fig. 2J, arrow) . 
Overexpression of vegf 121 and vegf 165 stimulates the expression of vascular endothelial cell-specific genes
To study the function of vegf in the zebrafish, we overexpressed the protein by injecting the two vegf mRNAs at 1:1 ratio together into 1-4 cell stage zebrafish embryos. At 22-23 or 30 hpf, embryos injected with vegf RNAs have highly increased flk1 expression in the entire vasculature of the embryo (Fig. 3B ) compared to control embryos (Fig. 3A) . In the head region, flk1 expressing cells are much more numerous and the transcript levels are considerably increased (compare Fig. 3C,D) . In the injected embryos, the vessels are often dilated with very large lumens (compare Fig. 3E,F) . In the trunk, flk1 expression is greatly up-regulated with higher transcript levels in the dorsal aorta and the axial vein as well as the appearance of ectopic flk1 positive cells between the dorsal aorta and the axial vein (compare Fig. 3G ,H and I,J). In some embryos, the entire area between the two major trunk vessels is filled with flk1 positive cells (Fig. 3H,J) . High levels of flk1 were also observed in the endocardium of the injected embryos (data not shown).
The orphan receptor tyrosine kinase gene, tie1, is first expressed at 18 hpf in endothelial cells, 6 h after the onset of flk1 expression (Liao et al., 1997; Lyons et al., 1998) . Coinjection of both vegf isoform mRNAs results in marked upregulation throughout the entire vessel system in the embryo including an obviously thickened endocardial cell layer positive for tie1 ( Fig. 3K-M ; Stainier et al., 1995) . However, we did not observe ectopic tie1-expressing cells in the space between the dorsal aorta and the axial vein (data not shown). No flk1 and tie1 up-regulations were observed in control embryos injected with similar amounts of b-gal mRNA or water (Fig. 3A,C ,E,G,I,K).
2.4. Zebrafish vegf stimulates hematopoietic-specific gene expression and promotes the production and/or differentiation of primitive hematopoietic cells in early embryonic stages
We also assayed for the effects of vegf overexpression on hematopoietic markers, scl and gata1. scl (also known as tal-1) is expressed in the zebrafish, as in other vertebrate embryos, in both hematopoietic and endothelial progenitors and in the central nervous system (Green et al., 1991 (Green et al., , 1992 Fig. 3 . Vegf stimulates vascular endothelial marker gene expression. Embryos injected with a 1:1 mixture of vegf 121 and vegf 165 RNAs or control embryos were fixed at 22 (G-J) or 30 hpf (A-F, K, L) and processed for in situ hybridization. Whole-mounted embryos are shown with anterior to the left (A, B, G, H, K, L) or with anterior to the top (E, F). Transverse sections of the embryo at the level of the midbrain (C, D), trunk (I, J), and heart (M) were photographed after handsectioning the stained embryos. Injected embryos were labeled as 'i' and uninjected embryos were labeled as 'c'. Kallianpur et al., 1994; Drake et al., 1997; Gering et al., 1998; Liao et al., 1998; Thomoson et al., 1998; Amatruda and Zon, 1999) . Targeted disruption of the scl gene in mouse leads to failure to form all blood lineages (Shivdasani et al., 1995; Robb et al., 1995 Robb et al., , 1996 and scl has been shown to be essential for angiogenesis in the yolk sac (Visvader et al., 1998) . When we injected the two vegf mRNAs into wildtype zebrafish embryos, we observed greatly increased scl expression in regions in and around the vasculature and in the peri-anal region (compare Fig. 4A and B) . However, the normal levels of scl expression within the central nervous system were not perturbed in the injected embryos. Since scl is known to be expressed in both endothelial and hematopoietic tissues, we could not be certain if the increased expression was derived from cells in both the lineages. However, the punctuated pattern of expression within the ventral trunk region suggested that some of the expression might be occurring within blood cell precursors and circulating blood cells.
gata1 is an early marker of blood differentiation in zebra- fish and is not expressed in the endothelial cells. Surprisingly, we observed a great increase in gata1 expression in most of the injected embryos (compare Fig. 4C and D). Not only was the level of expression more intense, but also many more cells expressed the gene. It has been shown that in early zebrafish embryogenesis, all hematopoietic cells belong to the erythroid lineage (Amatruda and Zon, 1999) . To further confirm that vegf can indeed stimulate the differentiation of red blood cells in zebrafish, hemoglobin staining was carried out at 30 hpf. As shown in Fig. 4E -J, there is a dramatic increase in hemoglobin staining in the circulation of vegf-injected embryos, indicating the presence of more differentiated red blood cells. Abnormal blood cell poolings at the posterior ICM or the merging point of the two dorsal aortae were prevalent. Furthermore, overexpression of vegf also resulted in obvious pericardial edema in many embryos as early as 30 hpf (Fig. 3F) . By 50 hpf, the pericardial edema in vegfinjected embryos became more severe while abnormal blood poolings remained widespread (Fig. 3K,L) .
These results indicate that in zebrafish, vegf not only functions to induce the formation of endothelial cells, but also to increase the expression of a hematopoietic-specific gene gata1 and to promote the differentiation and/or production of primitive red blood cells. No marker gene up-regulations and increased hemoglobin staining were observed in control embryos injected with a similar amount of b-gal mRNA or water (Figs. 3A, C,E,G,I,K and 4A,C,E,G,I).
2.5. Co-injection of both vegf isoform mRNAs results in earlier expression onset of both vascular and hematopoietic-specific genes From the above results, it is clear that vegf can stimulate not only differentiated endothelial cells and blood cells to express more of flk1, tie1, scl, and gata1 marker genes, but can also stimulate the embryos to generate more of the two cell types. Since vegf is expressed from about 8 to 8.5 hpf, much earlier than the four marker genes tested, we were interested if cells at stages prior to the normal expression of the marker genes were competent to respond to increased levels of Vegf. As shown in Fig. 5 and Table 1 , vegf RNAinjected embryos begin to express flk1 in scattered cells as early as 10 hpf (Fig. 5B) , at least 2 h prior to the normal initiation of expression of this marker gene (Fouquet et al., 1997; Liao et al., 1997) . Transverse sections of these embryos show that the early expressing cells are located in the hypoblast layer (Fig. 5C ). Expression of tie1 could be first observed in injected embryos at 16-17 hpf in scattered cells in the mid-trunk region (Fig. 5E ), whereas normal expression is first detected at 18 hpf (Liao et al., 1997) . Transverse sections show that the early expressing cells are located in the regions that will form the ICM (Fig.  5F ). Interestingly, embryos injected with vegf RNAs express high levels of both scl and gata1 at 10 hpf (Fig. 5H,I ,K,L). Cross-sections reveal that although most of the expressing cells are in the hypoblast, some also appear in the epiblast layer (Fig. 5L) . Thus, ectopic vegf can not only precociously induce the expression of a hematopoietic cell marker, but also can induce the marker in ectodermal cells that would not normally differentiate into blood. The strong early expression of scl in the 10 hpf embryos probably represents hematopoietic rather than endothelial precursors since the number of flk1 positive cells is much lower in these embryos. In situ hybridization using dig-labeled b-gal or plasmid sequence probes generated no positive staining in any of the embryos indicating that no probe trapping occurred as a result of vegf mRNA injection. Furthermore, no marker gene expression early onsets were observed in embryos injected with similar amount of b-gal mRNA or water (Fig. 5A,D,G,J) .
These results with earlier embryos confirmed our observation in older embryos that vegf expression can induce both endothelial and hematopoietic cell differentiation by stimulating specific gene expression characteristics of each of these lineages in zebrafish.
Overexpression of vegf increased the steady state mRNA levels of flk1 and gata1 genes
To confirm the stimulation of endothelial as well as hematopoietic-specific genes by vegf, semi-quantitative RT-PCR (relative RT-PCR) was used to quantify the amount of flk1 and gata1 mRNA in vegf-injected embryos at 10 and 30 hpf. Total RNAs were isolated from vegf mRNA and b-gal mRNA-injected embryos at both developmental stages and used in semi-quantitative RT-PCR analyses. As shown in Fig. 6 , there is significant up-regulation of both genes in vegf-injected embryos at both developmental stages, confirming the in situ analyses above. The house-keeping gene b -actin is expressed at the same levels in all samples, confirming that equal amount of total RNA were present in the RT-PCR reactions.
2.7. Co-injection of vegf RNAs of both isoforms is more effective than either isoform alone in stimulating flk1, tie1, and scl
From the RT-PCR analysis described above, the two vegf isoforms co-exist in most of the embryonic stages (Fig. 1) . Most likely, both isoforms function together to promote a The data shown are the results of three individual injection experiments. The embryos were injected at 1-4 cell stage. Approximately 2-3 nl of the mixture of vegf 121 1 vegf 165 RNAs (1:1) were injected in each embryo and the final concentration of either RNA was 500 ng/ml. From each injection experiment, part of the embryos (approximately half) was randomly selected for sequential in situ hybridizations. Each injection resulted in similar percentage of embryos, which show early onset of the marker gene expression. Control injections with b-gal mRNA showed similar results as the water injection (data not shown). vascular development. To compare the expression of the vascular markers in the presence of either vegf isoform alone or in the presence of the two isoforms together, we injected embryos with equal amount of either vegf 121 RNA, vegf 165 RNA, or a 1:1 mix of the two RNAs and compared expression of flk1, tie1, and scl at 30 hpf with uninjected embryos. As shown in Fig. 7 , each of the two isoforms was capable of increasing the amount of flk1, tie1(data not shown), or scl transcript in the embryo, but the combination of the two isoforms appeared to be more effective than either isoform alone. Since the overall amount of injected RNA was the same, the two isoforms seem to act synergistically to increase the level of flk1 and scl in the 30 hpf embryo. The increased flk1 expression observed in the embryos injected with both isoform RNAs was most pronounced in the trunk and tail regions (Fig. 7) . Dorsal view of these embryos shows a more extensive ectopic trunk vasculature in embryos injected with both isoform RNAs. In the head and heart, ectopic expression of the individual isoforms appeared to be as effective as ectopic expression of the two isoforms together in increasing flk1 transcript level. The stimulation of the tie1 expression with both isoforms was also reproducibly more effective than either isoform alone, but not as dramatic as flk1 (data not shown). Similarly, simultaneous ectopic expression of both vegf isoforms also increased scl expression over that seen with the ectopic expression of the individual isoforms (Fig.  7) . In this case, the increased expression was most often due to a more widespread ectopic expression throughout the tail and trunk region (ectopic expression was not seen in the head).
Expression of vegf in mutant embryos
2.8.1. Cloche Cloche (clo) is a recessive lethal mutant which has defi- ciency in both the endothelial and hematopoietic lineages (Stainier et al., 1995; Liao et al., 1997) . Homozygous clo mutant embryos share some common features with VEGF 2/2 mouse embryo such as a lack of the dorsal aorta. flk1 expression is mostly deleted in the clo embryos except in the lower trunk region of the zebrafish embryo, while tie1 expression is completely lost (Liao et al., 1997) . Expressions of scl and gata1 are also absent in early clo embryos, although low level of gata1 is expressed at later stages (Liao et al., 1998) . The possibility that vegf is identical to clo has been eliminated by mapping vegf (LG16) to a different linkage group to clo (LG13) (ZFIN: http://zfin.org/; Liao et al., 2000) .
To determine whether clo affects the expression of vegf, in situ hybridizations were carried out in the clo embryos. Normal vegf expression was observed in the clo embryos from 18-19 to 36 hpf in all areas, except that the pronephros expression was consistently found to be missing (Fig. 8) . It seems that the vegf expression is essentially independent of the clo function, with the possible exception in the developing pronephros. To further examine the relationship between vegf and clo, we injected synthetic vegf 121 and vegf 165 together into 1-4 cell stage embryos obtained from crosses of clo heterozygote fishes. However, in contrast to the consistent up-regulation of vascular and blood cell marker genes by vegf overexpression in wild-type and clo heterozygote embryos, only a few vegf-injected clo homozygote embryos showed weak and partial up-regulation of the marker genes after analyzing a large number of injected clo embryos (data not shown). These results indicate that vegf most likely cannot effectively rescue clo deficiencies and possibly functions up-stream of, or in parallel to, clo in zebrafish vasculogenesis and hematopoiesis.
No tail and floating head
The notochord has been shown to play critical roles in patterning the axial vessels, especially the dorsal aorta in zebrafish (Sumoy et al., 1997; Fouquet et al., 1997) . However, it is not clear whether notochord directly provides signals for patterning the vasculature or if it organizes other adjacent tissues, which then provide the signals for vessel formation. From the expression analysis above, vegf is found to be expressed only in areas of the somites, which are adjacent to the notochord (Fig. 2G,J ; Liang et al., 1998) . This expression pattern suggests that the notochord might have a role in regulating the vegf expression in somites. To analyze the role of notochord in regulating somite vegf gene expression, we performed in situ vegf hybridization on flh and ntl embryos, two zebrafish mutants that have defects in notochord formation. As shown in Fig. 9 , as early as 18-19 hpf when the vascular defects in the two mutants can be detected, vegf expression in somites of the two mutant embryos was completely absent, while the anterior expression domains were unperturbed. This vegf expression pattern correlates with flk1 expression in trunk regions of the two mutants without any change of expression pattern in the anterior regions (Sumoy et al., 1997) . At 24 and 36 hpf, the vegf expression in the pronephros was retained in both mutants while the somite expression was distinctly absent. These results indicate that the expression of vegf in somites is dependent on the presence of the notochord. It is noted that the normal vegf expression in the pronephros in flh mutant correlated with the presence of developed pronephros in this mutant (Talbot et al., 1995; Drummond et al., 1998; Majumdar and Drummond, 1999) .
Discussion
Comparison of zebrafish vegf expression in embryogenesis with other vertebrates
In zebrafish, expression of the VEGFR-2 gene flk1 marks the common precursor cells in the ICM that differentiate into endothelial and blood cells (Liao et al., 1997; Fouquet et al., 1997; Sumoy et al., 1997) . In this study, we show that the zebrafish vegf mRNA is present as maternal transcript in fertilized eggs and zygotic expression precedes that of its receptor flk1 by about 4 h, starting at midgastrula. Throughout the zebrafish embryogenesis, vegf expression is mostly associated in a spatial and temporal fashion with tissues that are in active vascularization. For example, vegf and flk1 transcripts are co-localized in the peri-anal area at 48 hpf, an active site of zebrafish embryonic hematopoiesis and possibly vasculogenesis and angiogenesis. Similar to Xenopus, zebrafish vegf is mostly expressed in mesoderm rather than in endoderm as in mammals and birds. However, the strong hypochord expression found in Xenopus (Cleaver et al., 1997) seems to be not so obvious in zebrafish. It is possible that the somite areas adjacent to the notochord could function as a major source of VEGF during trunk and tail vascularization. We also found that vegf is expressed very strongly in Fig. 8 . vegf expression in clo embryos. vegf in situ hybridization in 36 hpf embryos are shown. The expression in the glomeruli in the wild-type embryos is indicated by arrow. The anterior pronephric ducts expression cannot be seen in the dorsal view figure. the developing glomeruli as well as the anterior pronephric ducts during the second day of embryonic development ( Fig. 2) . This latter expression site was not found by Majumdar et al. (2000) , who reported that vegf is expressed in the glomeruli only.
Similar to human, Vegf 121 and Vegf 165 are the two most abundant isoforms in the zebrafish (Fig. 1) . However, only one VEGF receptor (VEGFR-2, flk1) has been reported from the zebrafish in contrast to two high-affinity VEGF receptors identified from mammalian species, Flt-1 (VEGFR-1) and Flk-1 (VEGFR-2) (Neufeld et al., 1999) . Another related tyrosine kinase receptor Flt-4 (VEGFR-3) binds only to VEGF-C and VEGF-D, but not to VEGF (Gale and Yancopoulos, 1999) . Because the zebrafish flk1 sequence also has some sequence homology with Flt-1 in mammals, it has been hypothesized that the zebrafish flk1 represents an ancestral gene which later diversified into Flk-1 and Flt-1 in higher vertebrates (Liao et al., 1997) . In support of this, no identification of Flt-1 from avian and amphibian species has been reported so far. In mammals, six homologous genes in the VEGF family have been discovered, VEGF (VEGF-A), VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PlGF (Neufeld et al., 1999) . As no other gene from the VEGF family has been identified in zebrafish so far, it is not known whether other vegf related genes exist in zebrafish and play a role in the vascular patterning. Furthermore, whether the zebrafish Vegf can bind and function through other related VEGFRs, such as the zebrafish flt4 is currently unknown. Relevantly, zebrafish flt4 has in fact been found to be expressed in blood vessel endothelial cells (Thomoson et al., 1998) . The possible multiplicity of VEGF ligands and VEGF receptors may explain why we found areas of the embryo that expressed flk1 but not vegf. In addition, neuropilin-1 and neuropilin-2, two neuroreceptors that are recently found to be expressed in the endothelial cells, function as isoform-specific receptors, which bind to VEGF 165 specifically (Soker et al., 1998) . This discovery, together with the identification of the Eph receptor family, has linked development of the vascular system and the nervous system during embryogenesis (Gale and Yancopoulos, 1999) . Indeed, mouse knock-out studies indicate a requirement for neuropilin-1 in embryonic vessel formation (Kawasaki et al., 1999) . Zebrafish neuropilin genes have recently been identified and are expressed during early zebrafish neurogenesis (our unpublished results). Whether vegf also functions through the neuropilins in the zebrafish is currently under investigation.
The role of zebrafish vegf in early embryonic development: comparison with loss of function studies in zebrafish and other vertebrates
To study the function of vegf in zebrafish, we overexpressed the two Vegf isoforms, either singly or together. To our surprise, overexpression of vegf stimulated not only the expression of endothelial marker genes flk1 and tie1, but also the blood marker genes scl and gata1. Furthermore, more cells in the injected embryos expressed these markers. These results indicate that the zebrafish vegf gene acts not only up-stream of flk1 and tie1 in stimulating endothelial lineage development, but it may also play a role up-stream of gata1 to stimulate the formation of the blood lineage. The later finding is in contrast to most other studies reported from other species, which indicate that VEGF acts specifically on the endothelial cell lineage (reviewed in Neufeld et al., 1999) . However, a recent report has shown that Flk-1 is present in human postnatal hematopoietic stem cells and that VEGF can stimulate the formation of these Flk-1 positive stem cells (Ziegler et al., 1999) .
Although our results indicate that vegf can stimulate both endothelial and hematopoietic lineages in zebrafish, the vegf morpholino antisense knock-down resulted in vascular abnormalities but no reduction in red blood cell levels (Nasevicius et al., 2000) . One possibility to explain this discrepancy is that vegf is indeed required for the formation of the hematopoietic lineage in zebrafish, but that the level of morpholino antisense oligonucleotide required to inhibit this induction is much greater than that required to inhibit vascular development. Another possiblity is that vegf acts redundantly in parallel to other factors in stimulating formation of the blood lineage. If this were the case, the vegf morpholino knock-down would have no effect on blood formation. Our observation that scl expression is stimulated by ectopic expression of vegf suggests that vegf may act to promote the formation of the common precursor to both endothelial and hematopoietic cells, the hemangioblast. It is also possible that the stimulation of blood formation induced by ectopic expression of vegf does not actually reflect a physiological role of vegf in the embryo, but is the result of abnormally high levels of expression of the Vegf protein. Even if this was the case, the result is still of interest for potential therapeutic applications. As gata1 is a blood-specific gene which is only expressed in the erythroid-myeloid progenitor cells that are flk1 negative (Amatruda and Zon, 1999; Parker et al., 1999) , vegf may function through another receptor in zebrafish to directly stimulate hematopoiesis. Alternatively, vegf may function indirectly by stimulating genes which can activate gata1.
Overexpression of vegf resulted in pericardial edema, excess red blood cell production as well as abnormal blood cell pooling at the posterior ICM or the merging point of the two dorsal aortae (Fig. 4) . This phenotype has some similarity with the vegf morphant zebrafish in which vegf expression was inhibited by morpholino-based gene knock-down method (Nasevicius et al., 2000) . However, in vegf morphant zebrafish, only occasional red blood cell accumulations were noted in the ventral tail region. In the vegf gain of function zebrafish of this study, increased red blood cell production as well as abnormal blood cell pooling were present in most of the injected embryos. It is possible that the effect of the pericardial edema, increased blood cell production, and abnormal blood cell circulation is a secondary effect of abnormal or defective vasculature formed under these conditions. In this regard, both vegf knockdown and vegf overexpression could generate defective vasculatures, resulting in pericardial edema and abnormal blood cell accumulation. In support of this, the reduced cardiac lumen due to endocardium hyperplasia in the presence of excess Vegf may result in the obstruction of intra-cardiac blood flow, leading to pericardial fluid accumulation (Fig. 3M) . On the other hand, overproduction of vegf can also cause pericardial edema by increasing the vascular permeability of the vessels as VEGF is also a potent vascular permeability factor (VPF) (Ferrara and Davis-Smyth, 1997) .
Several other groups have investigated the effects of VEGF overexpression in vivo in other vertebrate species. Flamme et al. (1995b) reported that VEGF overexpression in quail embryos leads to an increase in the complexity of the vascular network and up-regulation of Flk-1. Drake and Little (1995) observed a perturbation of the vascular organization and an increase in vessel diameter by VEGF in the quail embryos. Wilting et al. (1996) reported a specific induction of Flk-1 expression by VEGF 121 in capillaries that normally do not express this receptor in chick chorioallantoic membrane. Cleaver et al. (1997) found that ectopically expressed VEGF altered the pattern of vascular development in the early Xenopus embryo. Our results reported here show that VEGF can stimulate not only increased blood vessel formation, but also formation of blood cells in early embryogenesis. Furthermore, the combination of the two vegf isoforms stimulated the up-regulation of flk1, tie1, and scl to levels above that of the either isoform alone. It has been recently shown that VEGF 120 alone in mouse (equivalent to zebrafish vegf 121 ) is insufficient for normal angiogenesis and different VEGF isoforms most likely function complementarily for an optimal and comprehensive angiogenic response in vivo (Carmeliet et al., 1999) . Our results suggest that distinct functions of VEGF isoforms may exist in zebrafish embryonic development as well.
vegf expression in mutant embryos
vegf expression is generally not obviously affected in clo embryos, except that its expression in the pronephros are missing (Fig. 8) . This is in accordance with the lack of a vasculature in the developing pronephros in this mutant (Majumdar and Drummond, 1999) . So it seems that vegf expression is mostly independent of clo function. However, as vegf cannot effectively rescue clo phenotype in terms of flk1, tie1, scl, and gata1 expression easily, the relationship between these two genes in the genetic hierarchy governing vasculogenesis and hematopoiesis is not clear at the moment.
In ntl and flh mutants, vegf expression in the somite regions adjacent to the notochord are completely absent while the anterior expression is intact. Since notochord has been shown to be important for formation of the dorsal aorta, we postulate that notochord signals somites to express vegf, which in turn functions as a signal for dorsal aorta patterning as previously suggested (Weinstein, 1999) .
In conclusion, vegf functions as a potent growth factor to stimulate not only vasculogenesis and angiogenesis, but also hematopoiesis during zebrafish early embryogenesis. It can promote the early differentiation of endothelial cells as well as blood cells from their mesodermal precursor cells. Furthermore, Vegf 165 and Vegf 121 isoforms together function more potently than either isoform alone in these functions.
Experimental procedures
Fish care
Zebrafish embryos were raised at 28.58C under standard conditions (Westerfield, 1995) . The brass stock, used for in situ hybridization of Figs. 2-5, was originally obtained from EkkWill Waterlife Resources (Gibbonston, FL, USA). 
Whole-mount in situ hybridization and hemoglobin staining
Synthesis of digoxigenin-labeled flk1, tie1, scl, and gata1 antisense RNA probes and whole-mount in situ hybridizations were performed essentially as described in Li et al. (1994) and modified as follows: hybridization and the subsequent washes were carried out at 708C and the first post-hybridization solution contained 50% rather than 37.5% formamide. Embryos were either manually sectioned as described previously (Li et al., 1994) or sectioned using a cryostat. Hemoglobin staining with diaminofluorene (DAF) was performed as described in Weinstein et al. (1996) .
Preparation of expression constructs of vegf 165 and vegf 121 and microinjection
The full-length vegf 165 and vegf 121 were subcloned into the EcoRI site of plasmid pCS21. Clones with sense orientation were confirmed by sequencing. mRNA was synthesized in vitro with SP6 RNA Polymerase (Promega, USA) and resuspended in injection buffer, aliquoted, and stored at 2708C. Agarose molds used to hold embryos during microinjection (as described in Westerfield, 1995) were prepared the night before and equilibrated to 288C before use. Embryos were pressure injected with a N 2 driven Microinjector 5242 (Eppendorf Co., USA) under a standard dissecting microscope. Control embryos were injected with deionized H 2 O or equal amount of b-gal mRNA.
